Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Barlogie

Showing results (1-10 of 330) with videos related to

Pageof 33
Sort By:
Seminars in Hematology|March 16, 2004
Thalidomide and CC-5013 in multiple myeloma: the University of Arkansas experienceBart Barlogie
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
The role of transplant in multiple myelomaBart Barlogie
Cell Cycle (Georgetown, Tex.)|June 23, 2018
Imipridone ONC201: combination therapy in hematologic malignanciesAjai Chari, Bart Barlogie
Blood|July 23, 2011
Could CR mean cure?Bart Barlogie, John Crowley
Blood|October 23, 2012
Prognostic implications of cumulative dosing in total therapy 3Bart Barlogie, John Crowley
Blood|October 20, 2018
Walking on myelomaBart Barlogie, Joshua Richter
PET Clinics|May 16, 2019
PET-Computed Tomography in Myeloma: Current Overview and Future DirectionsDeepu Madduri, Bart Barlogie
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Using genomics to identify high-risk myeloma after autologous stem cell transplantationJohn D Shaughnessy, Bart Barlogie
International Journal of Hematology|November 15, 2002
Early results of total therapy II in multiple myeloma: implications of cytogenetics and FISHBart Barlogie, John D Shaughnessy
International Journal of Hematology|November 15, 2002
Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myelomaJohn D Shaughnessy, Bart Barlogie
Pageof 33

Showing results (1-10 of 330) with videos related to

Sort By:
Pageof 33
Seminars in Hematology|March 16, 2004
Thalidomide and CC-5013 in multiple myeloma: the University of Arkansas experienceBart Barlogie
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
The role of transplant in multiple myelomaBart Barlogie
Cell Cycle (Georgetown, Tex.)|June 23, 2018
Imipridone ONC201: combination therapy in hematologic malignanciesAjai Chari, Bart Barlogie
Blood|July 23, 2011
Could CR mean cure?Bart Barlogie, John Crowley
Blood|October 23, 2012
Prognostic implications of cumulative dosing in total therapy 3Bart Barlogie, John Crowley
Blood|October 20, 2018
Walking on myelomaBart Barlogie, Joshua Richter
PET Clinics|May 16, 2019
PET-Computed Tomography in Myeloma: Current Overview and Future DirectionsDeepu Madduri, Bart Barlogie
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
Using genomics to identify high-risk myeloma after autologous stem cell transplantationJohn D Shaughnessy, Bart Barlogie
International Journal of Hematology|November 15, 2002
Early results of total therapy II in multiple myeloma: implications of cytogenetics and FISHBart Barlogie, John D Shaughnessy
International Journal of Hematology|November 15, 2002
Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myelomaJohn D Shaughnessy, Bart Barlogie
Pageof 33